Health Department seizes suspected unregistered injection products
HK01 · 6 SOURCESabout 1 hour ago5 MIN
Summary
Hong Kong’s Department of Health said it carried out raids on four beauty-service premises in Tsim Sha Tsui, Mong Kok, Tsuen Wan and Yuen Long on October 16 and October 20, seizing suspected Part 1 poisons and suspected unregistered pharmaceutical injection products. Among the items seized were 20 vials of Elravie Re2O, a South Korean aesthetic injection product described in reports as a so-called “corpse skin injection”, whose Korean-language packaging says it is for injection and claims to contain human tissue.
Key Points
- The Department of Health said more than 100 suspected Part 1 poison injections and more than 70 suspected unregistered pharmaceutical injection products were found at premises in Tsim Sha Tsui and Mong Kok.
- A 38-year-old woman was arrested during a joint operation with police at a Mong Kok premises on suspicion of illegal possession and commercial dealing involving human organs.
- The seized Elravie Re2O products are said on their packaging to contain human tissue, making them both a regulated product under the Human Organ Transplant Ordinance and a pharmaceutical product under the Pharmacy and Poisons Ordinance.
- The Department of Health said it had received an exemption application for the regulated product, but no exemption has been granted, and no application for pharmaceutical registration has been received.
- Director of Regulatory Affairs Fung Ying (封螢) said the product lacks clinical safety data and poses a public health risk, and reminded the public that injections are medical procedures.
Why It Matters
The case points to continuing enforcement against injectable treatments offered in beauty settings, where products may fall under both drug-control and human-tissue rules. For Hong Kong consumers, the immediate issue is that a venue presenting itself as a beauty parlour does not reduce the medical and legal risks tied to injection procedures.